Literature DB >> 1536069

Cardiac rehabilitation. Current status and future directions.

H Gattiker1, P Goins, C Dennis.   

Abstract

Comprehensive cardiac rehabilitation is more than exercise training for patients with coronary artery disease and now includes all aspects of secondary prevention. Exercise training is individually prescribed based on clinical status and therapeutic goals. Smoking cessation and abstinence and the treatment of hypercholesterolemia are integral to the rehabilitation process. Education and counseling are important adjuncts to treatment, especially soon after a coronary event. Vocational rehabilitation can be included simply and effectively in the rehabilitation process. Efficient and cost-effective cardiac rehabilitation is tailored to a patient's medical condition, risk factor evaluation, and vocational status. The future of cardiac rehabilitation will be linked to the success of training nonphysician health professionals to provide preventive services.

Entities:  

Mesh:

Year:  1992        PMID: 1536069      PMCID: PMC1003196     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


  50 in total

Review 1.  Circulatory adjustments to dynamic exercise and effect of physical training in normal subjects and in patients with coronary artery disease.

Authors:  J P Clausen
Journal:  Prog Cardiovasc Dis       Date:  1976 May-Jun       Impact factor: 8.194

2.  An overview of randomized trials of rehabilitation with exercise after myocardial infarction.

Authors:  G T O'Connor; J E Buring; S Yusuf; S Z Goldhaber; E M Olmstead; R S Paffenbarger; C H Hennekens
Journal:  Circulation       Date:  1989-08       Impact factor: 29.690

3.  Type A behavior and mortality from coronary heart disease.

Authors:  D R Ragland; R J Brand
Journal:  N Engl J Med       Date:  1988-01-14       Impact factor: 91.245

4.  Usefulness of myocardial ischemia as predictor of training effect in cardiac rehabilitation after acute myocardial infarction or coronary artery bypass grafting.

Authors:  P A Ades; M H Grunvald; R M Weiss; J S Hanson
Journal:  Am J Cardiol       Date:  1989-05-01       Impact factor: 2.778

5.  Exercise, lipoproteins, and coronary artery disease.

Authors:  R M Krauss
Journal:  Circulation       Date:  1989-05       Impact factor: 29.690

Review 6.  Refining the type A hypothesis: emergence of the hostility complex.

Authors:  R B Williams
Journal:  Am J Cardiol       Date:  1987-12-28       Impact factor: 2.778

7.  Reduction in sudden deaths by a multifactorial intervention programme after acute myocardial infarction.

Authors:  V Kallio; H Hämäläinen; J Hakkila; O J Luurila
Journal:  Lancet       Date:  1979-11-24       Impact factor: 79.321

Review 8.  Efficacy of cardiac rehabilitation services. With emphasis on patients after myocardial infarction.

Authors:  P Greenland; J S Chu
Journal:  Ann Intern Med       Date:  1988-10-15       Impact factor: 25.391

9.  Decline in the risk of myocardial infarction among women who stop smoking.

Authors:  L Rosenberg; J R Palmer; S Shapiro
Journal:  N Engl J Med       Date:  1990-01-25       Impact factor: 91.245

10.  Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts.

Authors:  D H Blankenhorn; S A Nessim; R L Johnson; M E Sanmarco; S P Azen; L Cashin-Hemphill
Journal:  JAMA       Date:  1987-06-19       Impact factor: 56.272

View more
  3 in total

1.  Cardiac rehabilitation.

Authors:  J Dinnes; J Kleijnen; M Leitner; D Thompson
Journal:  Qual Health Care       Date:  1999-03

2.  Why is cardiac rehabilitation not widely used?

Authors:  R F De Busk
Journal:  West J Med       Date:  1992-02

3.  Home-based versus hospital-based cardiac rehabilitation after myocardial infarction or revascularisation: design and rationale of the Birmingham Rehabilitation Uptake Maximisation Study (BRUM): a randomised controlled trial [ISRCTN72884263].

Authors:  Kate Jolly; Gregory Y H Lip; Josie Sandercock; Sheila M Greenfield; James P Raftery; Jonathan Mant; Rod Taylor; Deirdre Lane; Kaeng Wai Lee; A J Stevens
Journal:  BMC Cardiovasc Disord       Date:  2003-09-10       Impact factor: 2.298

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.